Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site.
The discovery offers a fresh batch of possible therapeutic targets as well as new diagnostic tools with the potential to predict and inhibit the spread of cancer (metastasis) in patients suffering from the disease.
The research, published recently in The Journal of Biological Chemistry, was conducted by TSRI Professor Donald G. Phinney, a nationally recognized authority in the study of adult bone marrow-derived stem cells, and a postdoctoral fellow in his laboratory, Christopher L. Haga.
In the new study, the scientists found that a cluster of seven microRNAs (miRNA) function cooperatively to repress a process known as epithelial-to-mesenchymal transition (EMT). While EMT is part of the normal biology of cell development in some parts of the body, the process has recently been implicated in two dangerous aspects of tumor growth—tumor metastasis and the growth of drug-resistant cancer stem cells.
MicroRNAs are tiny fragments of RNA found in all mammalian cells. They bind to messenger RNAs, a process that generally results in gene silencing. This cluster of miRNAs, located in a genetic region known as DLK1-DIO3, suppresses a specific signaling network in human cancers that primarily affect glands such as breast cancer.
"These results establish the DLKI-DIO3 miRNA cluster as a critical checkpoint regulating tumor growth and metastasis," said Phinney. "Our data shows that when this cluster is silenced, it accelerates tumorogenesis and proliferation by inducing EMT."
Silencing the DLK1-DIO3 genetic region is an early event for tumors, Phinney said, pointing out that micro-metastasis can be detected even in the early stages of breast cancer.
One of the seven miRNAs highlighted in the new study—MiR-544—appears to be potent in its powers of inhibition, repressing cancer cell proliferation by inducing Ataxia telangiectasia mutated (ATM), a protein involved in stopping the cell cycle once DNA damage is detected.
"What's interesting is that MiR-544 blocks cell growth in every tumor cell line we've put it into, so we're looking at it as a potential therapeutic target," Phinney said.
Phinney noted that dozens of miRNAs exist in the same genetic region. "It's possible there are other clusters that work together to affect tumor growth and metastasis," he said.
The new study, "MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Signaling Network," was supported by National Institutes of Health (grant R01 NS052301-01A2). For more information on the paper, see http://www.jbc.org/content/early/2012/10/26/jbc.M112.387761
Scripps Research Institute: http://www.scripps.edu
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Understanding aggressive tumors in pets may lead to better treatments for the nastiest forms of the disease in people
Anti-GM activists will never accept anything ‘unnatural’, but the genetically modified potato being developed in Norwich could be of tremendous benefit
A new study is the first rigorous test of a controversial idea: that the everyday interactions between caregiver and child can change the way autism develops
Emergency crews who spent months clearing up after the attacks on the World Trade Center in New York have higher rates of rheumatoid arthritis and lupus
Six years ago, husband-and-wife scientists used gene therapy to cure colorblindness in monkeys. Now they're trying to make it work for the millions of people with faulty color vision.
Faced with unreliable screening, many women with a high lifetime risk of cancer opt for preventative surgery, just as Jolie did.
CAIRO (Reuters) - A team from a Spanish university has discovered what Egyptian authorities are calling the world's oldest evidence of breast cancer in the 4,200-year-old skeleton of an adult woman.
Early efforts to test legal marijuana are finding that it's got lots of buzzworthy THC. But it can also have fungus, chemical residue and bacteria. What that means for health and safety isn't clear.
Should the government recommend lean meat as part of a healthy diet? That's emerged as a political flashpoint. The panel working on federal guidelines says the evidence on lean meat is muddled.
A new coating makes ketchup slide out of the bottle and toothpaste slip out of a tube, right down to the last drop. So why not put the slick surface on an Ebola suit so the virus doesn't stick?